The primary therapy for disseminated intravascular coagulation consists of

The primary therapy for disseminated intravascular coagulation consists of

• A. Fresh frozen plasma
• B. Heparin therapy
• C. Platelet transfusion
• D. Treatment of the underlying disorder

Answer: (D)

Disseminated intravascular coagulation is a secondary, consumptive process driven by an underlying trigger (such as sepsis, obstetric catastrophe, or malignancy). The key to stopping the ongoing coagulation activation is to identify and treat that underlying disorder. While components like fresh frozen plasma or platelets can be used to manage acute bleeding or restore factors and platelets, they do not address the cause of the coagulopathy. Heparin may be considered in select cases with predominant thrombosis and minimal bleeding, but it is not the primary solution. Therefore, treating the underlying disorder is the essential, central therapeutic step.

Disseminated intravascular coagulation is a secondary, consumptive process driven by an underlying trigger (such as sepsis, obstetric catastrophe, or malignancy). The key to stopping the ongoing coagulation activation is to identify and treat that underlying disorder. While components like fresh frozen plasma or platelets can be used to manage acute bleeding or restore factors and platelets, they do not address the cause of the coagulopathy. Heparin may be considered in select cases with predominant thrombosis and minimal bleeding, but it is not the primary solution. Therefore, treating the underlying disorder is the essential, central therapeutic step.